How to Get Ozempic Prescribed: Steps and Requirements

Getting Ozempic prescribed starts with a diagnosis of type 2 diabetes. Ozempic is FDA-approved exclusively for adults with type 2 diabetes, not for weight loss on its own, so your doctor will need to confirm that diagnosis before writing a prescription. The process involves lab work, a conversation about your medical history, and often a prior authorization from your insurance company.

What Ozempic Is Actually Approved For

Ozempic (semaglutide) has three FDA-approved uses, all tied to type 2 diabetes. It can be prescribed alongside diet and exercise to lower blood sugar, to reduce the risk of heart attack, stroke, or cardiovascular death in people with type 2 diabetes and existing heart disease, and to slow kidney disease progression in people with type 2 diabetes and chronic kidney disease.

It is not approved for weight loss. The weight loss version of semaglutide is a separate product called Wegovy, which is prescribed at higher doses and under different criteria. Doctors can legally prescribe Ozempic off-label for weight management, but insurance companies rarely cover it for that purpose. UnitedHealthcare’s prior authorization policy states explicitly that medications used for weight loss are “typically excluded from benefit coverage.”

The Lab Work You’ll Need

Before prescribing Ozempic, your doctor will order blood tests to confirm a type 2 diabetes diagnosis and check for conditions that could make the medication unsafe. Insurance companies like UnitedHealthcare require at least one of the following to approve coverage: an A1C of 6.5% or higher, a fasting blood sugar of 126 mg/dL or above, or a random blood sugar of 200 mg/dL or higher with symptoms of high blood sugar. If you were diagnosed more than two years ago, your medical records confirming that diagnosis may be sufficient.

Beyond the diabetes-specific tests, your provider will likely order a thyroid function test, a comprehensive metabolic panel, a lipid panel, a kidney profile, and an insulin resistance panel. These establish a baseline for monitoring side effects and tracking how your health markers change over time on the medication.

Who Can Write the Prescription

Any licensed physician, nurse practitioner, or physician assistant can prescribe Ozempic. You don’t need to see an endocrinologist. Your primary care provider handles Ozempic prescriptions routinely.

Telehealth is also an option. Platforms like Walgreens Weight Management connect you with a doctor or nurse practitioner through video visits. During the appointment, the provider reviews your BMI, medical history, and lab results, then recommends the most appropriate medication. These telehealth providers are affiliated with independently owned medical practices staffed by licensed physicians. Other major pharmacy chains and standalone telehealth companies offer similar services.

Getting Past Insurance Prior Authorization

Most insurance plans require prior authorization for Ozempic, which means your doctor’s office submits clinical documentation proving you meet the criteria. This typically includes your lab values confirming a type 2 diabetes diagnosis and chart notes from your provider. The insurance company reviews this and either approves or denies coverage.

The list price for any Ozempic pen is $1,027.51 for a one-month supply, regardless of dose. What you actually pay depends on your insurance plan, whether Ozempic is on your plan’s formulary, and how much of your deductible you’ve met. Novo Nordisk, the manufacturer, offers savings cards that can reduce your copay at the pharmacy, though eligibility restrictions apply. If your insurance denies coverage, your doctor can file an appeal or suggest alternatives that your plan prefers.

If you’re seeking semaglutide specifically for weight loss and don’t have type 2 diabetes, ask your doctor about Wegovy instead. It’s the same active ingredient at a higher dose, with an FDA approval for weight management in adults with a BMI of 30 or above (or 27 with a weight-related health condition).

Who Cannot Take Ozempic

Ozempic is contraindicated if you or a close family member has a history of medullary thyroid carcinoma, a rare type of thyroid cancer. It’s also off-limits for people with Multiple Endocrine Neoplasia syndrome type 2. If you’ve ever had a serious allergic reaction to semaglutide, you cannot use it. Your doctor will ask about these conditions before prescribing.

What Happens After You Get the Prescription

Ozempic follows a gradual dose increase schedule. You start at 0.25 mg once a week for the first four weeks. This starting dose is meant to let your body adjust and isn’t considered a treatment dose. At week five, your provider increases you to 0.5 mg weekly. From there, if your blood sugar needs more control, the dose can be increased to 1 mg, and eventually up to the maximum of 2 mg per week. Each increase happens after at least four weeks at the current dose.

You’ll inject Ozempic yourself using a prefilled pen, once a week on the same day each week. The injection goes into your stomach area, thigh, or upper arm. Your doctor’s office or pharmacist will walk you through how to use the pen during your first fill. Expect regular follow-up appointments, especially during the first few months, so your provider can check how your blood sugar is responding and adjust the dose accordingly.

Supply Is No Longer an Issue

Ozempic experienced significant supply shortages over the past two years, making it difficult for even eligible patients to fill prescriptions. As of February 2025, the FDA formally declared the semaglutide injection shortage resolved, confirming that supply meets or exceeds current demand across all Ozempic pen doses. You should be able to fill a prescription at most pharmacies without extended wait times.

Avoid Compounded Semaglutide

With Ozempic’s high price, some patients turn to compounding pharmacies that sell custom-made versions of semaglutide at lower cost. The FDA has raised serious concerns about these products. Compounded drugs are not reviewed for safety, effectiveness, or quality before being sold. As of July 2025, the FDA had received 605 adverse event reports linked to compounded semaglutide, some requiring hospitalization due to dosing errors. Some compounding pharmacies use salt forms of semaglutide (like semaglutide sodium or semaglutide acetate) that are chemically different from the active ingredient in Ozempic, and the FDA has no data confirming these versions work the same way.